Physician profile
Dwayne Ryan Barrow
NPI 1487282497
$2,200.15
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $152 · 2023: $221 · 2024: $1,827.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,101 · Food and Beverage: $947.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,101.02 |
| Food and Beverage | $947.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuronetics, INC. | $1,612.81 | 2024 | Neurostar Tms Therapy System |
| Janssen Pharmaceuticals, INC | $158.34 | 2021-2024 | Spravato |
| Alkermes, INC. | $130.95 | 2023 | Vivitrol |
| Axsome Therapeutics, INC. | $121.82 | 2024 | Auvelity |
| Orexo US, INC. | $48.76 | 2023-2024 | Zubsolv |
| Otsuka America Pharmaceutical, INC. | $40.31 | 2023-2024 | Abilify Mycite |
| Indivior INC. | $37.57 | 2021-2024 | Sublocade |
| Uswm, LLC | $31.68 | 2023 | Lucemyra, Zimhi |
| Braeburn INC. | $17.91 | 2023 | Brixadi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dwayne Barrow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.